These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10548672)

  • 21. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A; Krass I; Bajorek BV
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review.
    Marto JP; Kauppila LA; Jorge C; Calado S; Viana-Baptista M; Pinho-E-Melo T; Fonseca AC
    Stroke; 2019 Oct; 50(10):2813-2818. PubMed ID: 31436141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
    Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.
    Carneiro T; Dashkoff J; Leung LY; Nobleza COS; Marulanda-Londono E; Hathidara M; Koch S; Sur N; Boske A; Voetsch B; Aboul Nour H; Miller DJ; Daneshmand A; Shulman J; Curiale G; Greer DM; Romero JR; Anand P; Cervantes-Arslanian AM
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105201. PubMed ID: 33066885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update.
    Katzan IL; Hammer MD; Furlan AJ; Hixson ED; Nadzam DM;
    Stroke; 2003 Mar; 34(3):799-800. PubMed ID: 12624312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Tissue Plasminogen Activator Dosing on Patients Weighing More Than 100 kg on 3-Month Outcomes in Acute Ischemic Stroke.
    Garavaglia J; Sherman J; Yetzer H; Regier M; Smith M
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1041-1046. PubMed ID: 28129994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic.
    Goyal MS; Hoff BG; Williams J; Khoury N; Wiesehan R; Heitsch L; Panagos P; Vo KD; Benzinger T; Derdeyn CP; Lee JM; Ford AL
    Stroke; 2016 Apr; 47(4):1012-7. PubMed ID: 26892282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extending tissue plasminogen activator use to community and rural stroke patients.
    Merino JG; Silver B; Wong E; Foell B; Demaerschalk B; Tamayo A; Poncha F; Hachinski V;
    Stroke; 2002 Jan; 33(1):141-6. PubMed ID: 11779903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous tissue plasminogen activator for acute ischemic stroke: A Canadian hospital's experience.
    Chapman KM; Woolfenden AR; Graeb D; Johnston DC; Beckman J; Schulzer M; Teal PA
    Stroke; 2000 Dec; 31(12):2920-4. PubMed ID: 11108749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.